Phase 1 starting (fingers crossed) end of 2022. By mid 2023 we should have an indication on the success of the trial. It's focused on safety for patients so if the trial is not canceled mid way, we should be confident that it's going well.
- Forums
- ASX - By Stock
- Ann: PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS
PYC
pyc therapeutics limited
Add to My Watchlist
1.77%
!
$1.15

Phase 1 starting (fingers crossed) end of 2022. By mid 2023 we...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M |
Open | High | Low | Value | Volume |
$1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 592 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 4211 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 1.120 |
3 | 9261 | 1.100 |
1 | 2000 | 1.050 |
2 | 33803 | 1.000 |
1 | 1020 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.160 | 4211 | 1 |
1.175 | 10000 | 1 |
1.180 | 33000 | 2 |
1.200 | 25749 | 4 |
1.205 | 2270 | 1 |
Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |